The Glycoprotein GPNMB: A Secret Ingredient for Understanding Parkinson's Disease Etiology?
- PMID: 36321268
- DOI: 10.1002/mds.29264
The Glycoprotein GPNMB: A Secret Ingredient for Understanding Parkinson's Disease Etiology?
Keywords: GPNMB; Parkinson's disease; α-synuclein.
Comment on
-
GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.Science. 2022 Aug 19;377(6608):eabk0637. doi: 10.1126/science.abk0637. Epub 2022 Aug 19. Science. 2022. PMID: 35981040 Free PMC article.
References
-
- Kia DA, Zhang D, Guelfi S, et al. Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol 2021;78(4):464-472. https://doi.org/10.1001/jamaneurol.2020.5257
-
- Diaz-Ortiz ME, Seo Y, Posavi M, et al. GPNMB confers risk for Parkinson's disease through interaction with α-synuclein. Science 2022;377(6608):eabk0637. https://doi.org/10.1126/science.abk0637
-
- Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ. The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress. Neurobiol Dis 2018;120:1-11. https://doi.org/10.1016/j.nbd.2018.08.013
-
- Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X. Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open 2021;11:e046329. https://doi.org/10.1136/bmjopen-2020-046329
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
